Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
7 January 2016
Header
Header image
News

News

IMI Launches Two New Calls to Appeal to a Wide Range of Stakeholders
18 December 2015

The world’s largest public-private partnership in life sciences, the Innovative Medicines Initiative (IMI), has launched two new Calls for proposals, offering stakeholders from a variety [...] Read more

News

New IMS Report Highlights the Importance of Biosimilar Competition on Patient Access and Treatment Cost of Biological Medicines
16 December 2015

The European pharmaceutical industry welcomes the new report by IMS Health on ‘The Impact of Biosimilar Competition’. The new report, which was prepared by IMS Health [...] Read more

News

EFPIA Welcomes new Agreement on General Data Protection Regulation
16 December 2015

EFPIA welcomes the agreement reached yesterday by the European Institutions on the General Data Protection Regulation. Four years of negotiations have led us to a [...] Read more

From our blog

From our blog

ICH opens up for the world
06 January 2016 by Pär Tellner

The International Council for Harmonisation (ICH) is the most successful pharmaceutical harmonisation project in the world. The key to this success has been good and effective collaboration between industry and authority experts in the ICH groups, which serves to elaborate on guidelines concerning quality, safety, efficacy and multidisciplinary topics, e.g. the electronic Common Technical Document (e-CTD).

Read more

From our blog

Working together for patients: grants and donations
06 January 2016 by

Collaboration between industry, health professionals and healthcare organisations benefits patients. It is a relationship that has delivered numerous innovative medicines and changed the way many diseases impact on our lives. Industry and health professionals collaborate in a range of activities from clinical research to sharing best clinical practice and exchanging information on how new medicines fit into the patient pathway. 

Read more

Events calendar

Events Calendar

Inaugural Conference of the European Institute for Innovation through Health Data (i~HD)
On 10/03/2016 (Paris, France)

This Inaugural Conference will mark the parallel launch of a novel European platform to support multi-centre clinical research. This operational platform, the result of the European project EHR4CR (Electronic Health Records for Clinical Research), can connect securely to the data within multiple hospital EHR systems and clinical data warehouses across Europe, to enable a trial sponsor to predict the number of eligible patients for a candidate clinical trial protocol, to assess its feasibility and to locate the most relevant hospital sites.

The role of i~HD, as a not-for-profit Institute, is to provide independent governance oversight of such services now, and as these expand to connect with many more hospitals across Europe. The conference will present this platform and its pharma-led adoption programme, and detail the i~HD governance services that reflect state-of-the-art in the trustworthy re-use of health data for research. You will also learn about Europe's largest "big data" project in health: EMIF (European Medical Information Framework). The views of patients on the benefits of reusing their data for research will be presented by Mary Baker, past President of the European Brain Council, one of our keynote speakers.

For more information, please click here

Read more

Events Calendar

Biovision World Life Science Forum
From 13/04/2016 to 14/04/2016 (Lyon, France)

The Biovision World Life Science Forum is fostering a unique approach to meet and connect with, as well as collaborate between international decision-makers from the academic, civil society, policy-making and private sectors, whether industrial or investors.

Biovision 2016's pattern is dedicated to strengthening Action & Interaction for Innovation with:

  • A prospective part with a main theme on "Global health and Prevention" and specific paths (Medicine & Humanities, Vaccines, Cancer Prevention and Digitalised Patients) with workshops, plenary sessions and calls for action.
  • Catalyser & Investor parts with reinforced and segmented sourcing allowing more specific expertise for the evaluation and follow up of the projects, including financing.
Read more

Events Calendar

Certificate in European Healthcare Compliance Ethics & Regulation
From 11/01/2016 to 14/01/2016 (Paris, France)

PROGRAMME OVERVIEW

The pharmaceutical, biotech and medical device industries increasingly are facing a more challenging regulatory and enforcement landscape throughout Europe. This intensive, multi-day educational and training certification in healthcare compliance addresses the myriad of legal, regulatory and compliance issues faced by pharmaceutical, biotech and medical device manufacturers doing business in Europe. 

Read more

What we are reading

What we are reading

The impact of biosimilar competition on price, volume and market share
06 January 2016 (European Commission)

The increased biosimilar competition affects not just the price of the directly comparable product but also has an effect on the price of the whole product class. This is highlighted in a recent report on the impact of biosimilar competition conducted by IMS Health on the request of the European Commission.

The report, published on 16 December 2015, describes the effects on price, volume and market share following the market entry of biosimilars in the European Economic Area.

Read more

What we are reading

Gonorrhoea 'could become untreatable'
06 January 2016 (BBC Health)

Gonorrhoea could become an untreatable disease, England's chief medical officer has warned.

Dame Sally Davies has written to all GPs and pharmacies to ensure they are prescribing the correct drugs after the rise of "super-gonorrhoea" in Leeds.

Read more

What we are reading

Search for Ebola cure goes on as remedy based on survivors' blood underwhelms
07 January 2016 (The Guardian)

Study shows that treatment based on transfusion of plasma extracted from blood of recovered patients does not significantly improve survival rates

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail